Clinical Center; Notice of Closed Meeting, 59798 [06-8602]
Download as PDF
<![CDATA[
59798
Federal Register / Vol. 71, No. 196 / Wednesday, October 11, 2006 / Notices
of the actual period for patent extension.
In its application for patent extension,
this applicant seeks 1,713 days of patent
term extension.
Anyone with knowledge that any of
the dates as published are incorrect may
submit to the Division of Dockets
Management (see ADDRESSES) written or
electronic comments and ask for a
redetermination by December 11, 2006.
Furthermore, any interested person may
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period by
April 9, 2007. To meet its burden, the
petition must contain sufficient facts to
merit an FDA investigation. (See H.
Rept. 857, part 1, 98th Cong., 2d sess.,
pp. 41–42, 1984.) Petitions should be in
the format specified in 21 CFR 10.30.
Comments and petitions should be
submitted to the Division of Dockets
Management. Three copies of any
mailed information are to be submitted,
except that individuals may submit one
copy. Comments are to be identified
with the docket number found in
brackets in the heading of this
document.
Comments and petitions may be seen
in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
Dated: September 22, 2006.
Jane A. Axelrad,
Associate Director for Policy, Center for Drug
Evaluation and Research.
[FR Doc. E6–16816 Filed 10–10–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pwalker on PRODPC60 with NOTICES
Clinical Center; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors of the
NIH Clinical Center.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
Clinical Center, including consideration
of personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
VerDate Aug<31>2005
16:53 Oct 10, 2006
Jkt 211001
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors of the NIH Clinical Center.
Date: October 16, 2006.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate the
Rehabilitation Medicine Program.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: David K. Henderson, MD,
Deputy Director for Clinical Care, Office of
the Director, Clinical Center, National
Institutes of Health, Building 10, Room 6–
1480, Bethesda, MD 20892, 301/402–0244.
This notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the intramural research review cycle.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Dated: October 4, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8602 Filed 10–10–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting; Interagency Autism
Coordinating Committee
The National Institutes of Health
(NIH) hereby announces a meeting of
the Interagency Autism Coordinating
Committee (IACC) to be held on
November 17, 2006, on the NIH campus
in Bethesda, Maryland.
The Children’s Health Act of 2000
(Pub.L. 106–310), Title I, Section 104,
mandated the establishment of an
Interagency Autism Coordinating
Committee (IACC) to coordinate autism
research and other efforts within the
Department of Health and Human
Services (DHHS). In April 2001, the
HHS Secretary delegated the authority
to establish the IACC to the National
Institutes of Health (NIH). The National
Institute of Mental Health (NIMH) at the
NIH has been designated the lead for
this activity.
The IACC meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting.
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
Name of Committee: Interagency
Autism Coordinating Committee.
Date: November 17, 2006.
Time: 9 a.m.–4 p.m.
Agenda: Discussion of autism
activities across Federal agencies.
Place: National Institutes of Health,
Building 31, Conference Room 10 (6th
floor), 31 Center Drive, Bethesda,
Maryland 20892.
Contact Person: Ann Wagner, Ph.D.,
Division of Pediatric Translational
Research and Treatment Development,
National Institute of Mental Health,
NIH, 6001 Executive Boulevard, Room
6184, MSC 9617, Bethesda, Maryland
20892. E-mail: awagner@mail.nih.gov.
Phone: 301–443–5944.
Any member of the public interested
in presenting oral comments to the
Committee may notify the contact
person listed on this notice at least 5
days in advance of the meeting.
Interested individuals and
representatives of organizations may
submit a letter of intent, a brief
description of the organization
represented, and a short description of
the oral presentation. Presentations may
be limited to 5 minutes; both printed
and electronic copies are requested for
the record. In addition, any interested
person may file written comments with
the Committee by forwarding his/her
statement to the contact person listed on
this notice. The statement should
include the name, address, telephone
number, and, when applicable, the
business or professional affiliation of
the interested person.
Information about the meeting and
online registration forms are also
available on-line on the NIMH
homepage at https://www.nimh.nih.gov/
autismiacc/index.cfm.
Dated: September 29, 2006.
Raynard S. Kington, M.D., Ph.D.,
Deputy Director, National Institutes of Health.
[FR Doc. E6–16721 Filed 10–10–06; 8:45 am]
BILLING CODE 4167–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 522b(c)(6), Title 5 U.S.C.,
E:\FR\FM\11OCN1.SGM
11OCN1
]]>Agencies
[Federal Register Volume 71, Number 196 (Wednesday, October 11, 2006)]
[Notices]
[Page 59798]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8602]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors of the NIH Clinical Center.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the Clinical
Center, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors of the NIH
Clinical Center.
Date: October 16, 2006.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate the Rehabilitation Medicine
Program.
Place: National Institutes of Health, Building 10, 10 Center
Drive, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: David K. Henderson, MD, Deputy Director for
Clinical Care, Office of the Director, Clinical Center, National
Institutes of Health, Building 10, Room 6-1480, Bethesda, MD 20892,
301/402-0244.
This notice is being published less than 15 days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the intramural research review cycle.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Dated: October 4, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8602 Filed 10-10-06; 8:45 am]
BILLING CODE 4140-01-M
